awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35558057-0CD649B7-EE4D-462B-9FF9-9B97DBC7E6D7
Q35558057-0CD649B7-EE4D-462B-9FF9-9B97DBC7E6D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35558057-0CD649B7-EE4D-462B-9FF9-9B97DBC7E6D7
Novel and emerging targeted-based cancer therapy agents and methods.
P2860
Q35558057-0CD649B7-EE4D-462B-9FF9-9B97DBC7E6D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35558057-0CD649B7-EE4D-462B-9FF9-9B97DBC7E6D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f4874e4b7a635ee0f45fd83bb8615a43fd54196
P2860
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas.